Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Blood Specimen Collection × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Neoplasms 12 Colorectal Neoplasms 9 Lung Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Myelodysplastic Syndromes 5 Sarcoma 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Squamous Cell 3 Carcinoma, Hepatocellular 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Thrombosis 2 Skin Neoplasms 2 Sezary Syndrome 2 Myeloproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Hodgkin Disease 2 Head and Neck Neoplasms 2 Desmoid Tumors 2 Carcinoma, Renal Cell 2 COVID-19 2 Adenocarcinoma 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡